» Articles » PMID: 6518769

Designs for Group Sequential Tests

Overview
Publisher Elsevier
Date 1984 Dec 1
PMID 6518769
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Several authors have proposed group sequential procedures to satisfy the ethical need in clinical trials for interim analyses. We propose here an alternative procedure that offers a good opportunity for early termination when initial results are extreme, while essentially maintaining the power provided by the procedure that applies when the corresponding test statistic is computed only at the predetermined time of final analysis. The new design is also sufficiently flexible to readily allow one to increase the maximum number of analyses for certain reasons such as unexpectedly slow accrual into the study, although not for reasons arising from consideration of outcomes observed at interim analysis.

Citing Articles

Evaluation of oral cholera vaccine (Euvichol-Plus) effectiveness against in Bangladesh: an interim analysis.

Khanam F, Islam M, Ahmmed F, Rajib M, Hossen M, Chowdhury F BMJ Glob Health. 2025; 10(2).

PMID: 39900426 PMC: 11795403. DOI: 10.1136/bmjgh-2024-016571.


Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer.

Lee W, Dignam J, Amin M, Bruner D, Low D, Swanson G J Clin Oncol. 2024; 42(20):2377-2381.

PMID: 38759121 PMC: 11377096. DOI: 10.1200/JCO.23.02445.


Efficacy of Chinese Medicine Treatment Based on Syndrome Differentiation for Primary Insomnia: A Randomized Placebo Controlled Triple-Blinded Trial.

Xiong Z, Lu Y, He L, Zhang R, Zhou X, Li P Chin J Integr Med. 2024; 30(10):867-876.

PMID: 38753273 DOI: 10.1007/s11655-024-3661-4.


Using Bayesian statistics in confirmatory clinical trials in the regulatory setting: a tutorial review.

Lee S BMC Med Res Methodol. 2024; 24(1):110.

PMID: 38714936 PMC: 11077897. DOI: 10.1186/s12874-024-02235-0.


Futility monitoring for randomized clinical trials with non-proportional hazards: An optimal conditional power approach.

Wang X, George S Clin Trials. 2023; 20(6):603-612.

PMID: 37366172 PMC: 10751393. DOI: 10.1177/17407745231181908.